These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32735689)

  • 21. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management.
    Fekrazad R
    Photobiomodul Photomed Laser Surg; 2020 May; 38(5):255-257. PubMed ID: 32326830
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of Potential Therapeutic Options for COVID-19.
    Austin D; Okour M
    J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
    [No Abstract]   [Full Text] [Related]  

  • 23. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.
    South AM; Tomlinson L; Edmonston D; Hiremath S; Sparks MA
    Nat Rev Nephrol; 2020 Jun; 16(6):305-307. PubMed ID: 32246101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
    Ayaz S; Crea F
    Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
    [No Abstract]   [Full Text] [Related]  

  • 26. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 27. Antivirals for COVID-19 and Breastfeeding.
    Anderson PO
    Breastfeed Med; 2020 Oct; 15(10):605-607. PubMed ID: 32936682
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 29. Famotidine Against SARS-CoV2: A Hope or Hype?
    Ghosh R; Chatterjee S; Dubey S; Lavie CJ
    Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
    [No Abstract]   [Full Text] [Related]  

  • 30. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
    Jensen JD; Lynch M
    Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
    [No Abstract]   [Full Text] [Related]  

  • 31. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 32. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sofosbuvir as a potential option for the treatment of COVID-19.
    Nourian A; Khalili H
    Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plea for multitargeted interventions for severe COVID-19.
    Gaborit BJ; Bergmann JF; Mussini C; Arribas JR; Behrens G; Walmsley S; Pozniak A; Raffi F
    Lancet Infect Dis; 2020 Oct; 20(10):1122-1123. PubMed ID: 32325035
    [No Abstract]   [Full Text] [Related]  

  • 35. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
    Alany RG
    Pharm Dev Technol; 2020 Jul; 25(6):649. PubMed ID: 32423342
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescribing COVID-19 treatments: what we should never forget.
    Tunesi S; Bourgarit A
    J Infect; 2020 Aug; 81(2):e85. PubMed ID: 32405110
    [No Abstract]   [Full Text] [Related]  

  • 38. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.
    McCarty MF; DiNicolantonio JJ
    Prog Cardiovasc Dis; 2020; 63(3):383-385. PubMed ID: 32061635
    [No Abstract]   [Full Text] [Related]  

  • 39. [Brug af hydroxychloroquin til COVID-19].
    Bygbjerg IC
    Ugeskr Laeger; 2020 May; 182(20):. PubMed ID: 32400382
    [No Abstract]   [Full Text] [Related]  

  • 40. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.